Reproductive Physiology And Development - USMLE Step 1

SECTION 1

Historical Context & Motivation

The study of reproductive physiology spans centuries of incremental discovery, from early anatomical dissections to the molecular endocrinology that underpins modern reproductive medicine. Understanding how gametes form, how hormones orchestrate the menstrual and spermatogenic cycles, and how a fertilized ovum develops into a viable embryo is central to clinical practice in obstetrics, gynecology, urology, and endocrinology. For USMLE Step 1 preparation, this topic integrates embryology, histology, biochemistry, and pharmacology into a unified framework that frequently appears in both normal physiology and pathology vignettes.

1672 • de Graaf Describes the Ovarian Follicle

Regnier de Graaf identified the follicular structure of the ovary and proposed that it was the source of the female 'egg,' laying the groundwork for ovarian physiology.

1827 • von Baer Discovers the Mammalian Ovum

Karl Ernst von Baer observed the actual ovum within the Graafian follicle, confirming the ovistic theory of reproduction and establishing embryology as an experimental science.

1929 • Isolation of Estrogen

Edward Doisy and Adolf Butenandt independently isolated estrone, the first purified sex steroid, catalyzing the era of reproductive endocrinology and enabling pharmacologic manipulation of fertility.

1960 • FDA Approves the Oral Contraceptive Pill

The combined estrogen-progestin oral contraceptive leveraged knowledge of the hypothalamic-pituitary-gonadal (HPG) axis to suppress ovulation, translating basic reproductive physiology into one of the most widely used medications in history.

1978 • First In Vitro Fertilization Birth

Louise Brown's birth demonstrated clinical mastery of oocyte retrieval, capacitation, fertilization, and embryo implantation—integrating virtually every concept in reproductive development.

Each of these milestones addressed a fundamental question: how does the body coordinate the production, release, and union of gametes while simultaneously preparing a uterine environment capable of sustaining pregnancy? Answering this question requires an integrated understanding of the HPG axis, steroidogenesis, gametogenesis, fertilization, and early embryonic development—topics that collectively represent a high-yield domain on the USMLE Step 1 examination.

SECTION 2

Core Principles & Definitions

Reproductive physiology rests on a set of interlocking principles that govern hormonal signaling, gamete maturation, and developmental programming. Mastery of these principles provides the scaffolding for understanding both normal fertility and the pathophysiology of conditions such as polycystic ovarian syndrome (PCOS), hypogonadism, ectopic pregnancy, and disorders of sexual development (DSDs). The five foundational concepts below serve as the organizational backbone for the remainder of this lesson.

HPG Axis Regulation

The hypothalamic-pituitary-gonadal axis uses pulsatile GnRH release to drive anterior pituitary secretion of FSH and LH, which in turn regulate gonadal steroidogenesis and gametogenesis. Negative feedback loops from sex steroids and inhibins maintain homeostasis, while a critical positive feedback loop from estradiol triggers the LH surge.

Gametogenesis

Oogenesis begins in fetal life and arrests at prophase I until ovulation; spermatogenesis begins at puberty and continues throughout life. Both processes require meiosis to produce haploid gametes with 23 chromosomes.

Steroidogenesis

All sex steroids derive from cholesterol via a common enzymatic pathway. Key enzymes include cholesterol side-chain cleavage (CYP11A1), 17α-hydroxylase (CYP17), and aromatase (CYP19). Enzyme deficiencies produce predictable clinical phenotypes.

Fertilization & Implantation

Capacitated sperm undergo the acrosome reaction to penetrate the zona pellucida, triggering the cortical reaction that blocks polyspermy. The resulting zygote undergoes cleavage during transit through the fallopian tube and implants as a blastocyst around day 6–7.

Embryonic Development & Sexual Differentiation

Default gonadal development is ovarian unless the SRY gene on the Y chromosome induces testicular differentiation. Subsequent sexual phenotype depends on testosterone, DHT, and anti-Müllerian hormone (AMH) secretion.

✦

KEY TAKEAWAY

Think of the HPG axis as a thermostat system: the hypothalamus is the thermostat setting the desired temperature (GnRH pulse frequency and amplitude), the anterior pituitary is the furnace controller (FSH and LH output), and the gonads are the heating/cooling units (steroid and gamete production). Negative feedback from sex steroids 'turns down the furnace' when levels are sufficient—except at midcycle, when rising estradiol uniquely acts as positive feedback to trigger the LH surge, analogous to the thermostat deliberately overshooting to initiate a critical event (ovulation).

SECTION 3

The HPG Axis — Visual Overview

The HPG axis is depicted as a three-tier hierarchy. GnRH travels via the hypothalamic-hypophyseal portal system to stimulate gonadotrophs. FSH and LH then act on gonadal target cells. Red dashed arrows represent negative feedback by sex steroids and inhibins. The green pathway highlights the unique midcycle positive feedback of estradiol that triggers the LH surge.

The diagram above encapsulates the master regulatory circuit of human reproduction. Notice that the hypothalamus communicates with the anterior pituitary via a specialized portal venous system rather than the systemic circulation, allowing low-concentration pulses of GnRH to reach gonadotrophs without significant dilution. The pulsatile nature of GnRH is clinically exploitable: continuous GnRH administration (as with leuprolide) paradoxically downregulates GnRH receptors and suppresses gonadotropin release, a principle used in treating prostate cancer, endometriosis, and precocious puberty. In contrast, pulsatile GnRH pumps can restore fertility in hypothalamic amenorrhea.

💡

Clinical Pearl

GnRH pulse frequency determines the ratio of FSH to LH output. Low-frequency pulses (~every 90–120 minutes, as in the early follicular phase) favor FSH secretion, while high-frequency pulses (~every 60 minutes, as in the late follicular/luteal phase) favor LH secretion. This concept explains why the LH-to-FSH ratio is elevated in PCOS (abnormally high GnRH pulse frequency).

SECTION 4

Hormonal Mechanisms & Steroidogenesis

All gonadal steroids originate from a single precursor: cholesterol. The rate-limiting step in steroidogenesis is the transport of cholesterol from the outer to the inner mitochondrial membrane by steroidogenic acute regulatory protein (StAR), which is upregulated by LH (in theca and Leydig cells) and ACTH (in the adrenal cortex). Once inside the mitochondrion, cholesterol is cleaved by CYP11A1 (cholesterol desmolase) to form pregnenolone, the common precursor to all steroid hormones.

Two-Cell, Two-Gonadotropin Model (Ovary)

In the ovary, estrogen synthesis requires cooperation between two cell types. Theca interna cells express LH receptors and possess CYP17 (17α-hydroxylase/17,20-lyase), enabling them to convert cholesterol to androstenedione. However, theca cells lack aromatase (CYP19). Androstenedione therefore diffuses to adjacent granulosa cells, which express FSH receptors and aromatase, converting androstenedione to estradiol (E₂). This cooperative model explains why both FSH and LH are required for adequate estrogen production, and why isolated elevations of LH (as in PCOS) lead to hyperandrogenism without corresponding increases in estradiol.

STEROIDOGENIC PATHWAY (SIMPLIFIED)

Cholesterol → (CYP11A1) → Pregnenolone → (CYP17) → DHEA → (3β-HSD) → Androstenedione → (CYP19/Aromatase) → Estrone → (17β-HSD) → Estradiol (E₂)

CYP11A1 = cholesterol side-chain cleavage enzyme (rate-limiting after StAR transport); CYP17 = 17α-hydroxylase/17,20-lyase; 3β-HSD = 3β-hydroxysteroid dehydrogenase; CYP19 = aromatase; 17β-HSD = 17β-hydroxysteroid dehydrogenase. Each enzyme deficiency produces a characteristic clinical syndrome with predictable mineralocorticoid, glucocorticoid, and sex steroid abnormalities.

Testosterone and DHT (Testis)

In the male, Leydig cells of the testicular interstitium respond to LH by producing testosterone. Testosterone acts both as a circulating hormone and as a paracrine factor that supports spermatogenesis in adjacent seminiferous tubules. In peripheral tissues such as the prostate and external genitalia, testosterone is converted to the more potent androgen dihydrotestosterone (DHT) by the enzyme 5α-reductase. Deficiency of 5α-reductase (autosomal recessive) classically presents as ambiguous genitalia at birth with virilization at puberty—a high-yield USMLE vignette.

ANDROGEN CONVERSION

Testosterone → (5α-Reductase) → Dihydrotestosterone (DHT)

DHT has a higher affinity for the androgen receptor than testosterone and is essential for development of the prostate, male external genitalia, and male-pattern hair distribution. Finasteride (5α-reductase type II inhibitor) and dutasteride (dual type I/II inhibitor) are used clinically for BPH and androgenetic alopecia.

AROMATASE CONVERSION

Testosterone → (CYP19/Aromatase) → Estradiol (E₂)

Aromatase is expressed in adipose tissue, brain, bone, and gonads. Excess aromatase activity in obesity increases circulating estrogen, contributing to gynecomastia in males and irregular menses in females. Aromatase inhibitors (e.g., anastrozole, letrozole) are used in estrogen receptor-positive breast cancer and in ovulation induction protocols.

SECTION 5

The Menstrual Cycle, Oogenesis & Spermatogenesis

The menstrual cycle is a 28-day (average) integrated cycle that can be divided into ovarian phases (follicular and luteal) and uterine phases (menstrual, proliferative, and secretory). The follicular phase is variable in length and accounts for most cycle-to-cycle variation, whereas the luteal phase is consistently ~14 days. This fixed luteal phase duration is a classic USMLE fact: in a woman with a 35-day cycle, ovulation occurs approximately on day 21, not day 14.

Integrated view of the menstrual cycle showing hormonal profiles (top), ovarian phases (middle), and uterine/endometrial phases (bottom). The estradiol peak precedes the LH surge, which triggers ovulation. The progesterone rise dominates the luteal phase and maintains the secretory endometrium.

Oogenesis vs. Spermatogenesis

Feature	Oogenesis	Spermatogenesis
Onset	Fetal life (primary oocytes by 5th month)	Puberty (~age 12–13)
Meiotic arrest	Prophase I (until ovulation); Metaphase II (until fertilization)	No arrest; continuous process (~64 days per cycle)
Yield per meiosis	1 mature ovum + 2–3 polar bodies	4 mature spermatids per spermatocyte
Finite/renewable	Finite: ~1–2 million at birth → ~400,000 at puberty → ~400 ovulated	Renewable: spermatogonial stem cells maintained by niche
Key hormonal driver	FSH → granulosa cell support; LH surge → ovulation	FSH → Sertoli cells; Testosterone (paracrine) from Leydig cells
Site	Ovarian cortex (follicle)	Seminiferous tubules (34°C, 2°C below core temp)

Comparison of female and male gametogenesis — high-yield USMLE content

⚠

Board Alert

The oocyte arrested in metaphase II completes meiosis II only upon fertilization. If a question states that a cell is arrested at metaphase II, it is a secondary oocyte—not yet a mature ovum. This distinction is frequently tested.

SECTION 6

Worked Example: Identifying Hormonal Pathology from a Clinical Vignette

The following worked example mirrors the clinical vignette format of USMLE Step 1 and integrates the hormonal and developmental principles discussed above. Approach these questions by first identifying the physiologic pathway involved, then localizing the defect.

Clinical Vignette: 17α-Hydroxylase Deficiency

1
Step 1 — Read the Vignette

A 16-year-old 46,XY patient presents with female external genitalia, absent breast development, hypertension, and hypokalemia. Serum cortisol and sex steroids are low, ACTH is elevated, and serum levels of 11-deoxycorticosterone (DOC) and corticosterone are elevated. What enzyme is deficient?
2
Step 2 — Map the Steroid Pathway

Recall the steroidogenic pathway: Cholesterol → Pregnenolone → (via CYP17 / 17α-hydroxylase) → 17-OH Pregnenolone → DHEA → Androstenedione → Testosterone / Estradiol. A block at CYP17 would shunt all precursors into the mineralocorticoid pathway (DOC, corticosterone) because the 17-hydroxylation step required for cortisol and sex steroids is absent.

Precursors accumulate proximal to CYP17: ↑ DOC, ↑ corticosterone
3
Step 3 — Explain the Phenotype

Elevated DOC acts as a mineralocorticoid → Na⁺ and water retention → hypertension with suppressed renin and aldosterone. The hypokalemia results from DOC-driven renal K⁺ wasting. Since sex steroids (both androgens and estrogens) cannot be synthesized, a 46,XY individual cannot masculinize (no testosterone/DHT) and appears phenotypically female with female external genitalia, but also lacks estrogen for breast development.
4
Step 4 — Consider Internal Anatomy

The patient has testes (SRY gene present on Y chromosome), which produce anti-Müllerian hormone (AMH) from Sertoli cells. AMH causes regression of the Müllerian (paramesonephric) ducts, so there is no uterus or upper vagina. However, without testosterone, the Wolffian (mesonephric) ducts also regress. The patient thus has neither fully developed male nor female internal genitalia.

Answer: 17α-Hydroxylase (CYP17) deficiency — hypertension + hypokalemia + phenotypic female in 46,XY + absent sex steroids + elevated DOC/corticosterone.

💡

ENZYME DEFICIENCY FRAMEWORK

When evaluating congenital adrenal hyperplasia (CAH) and related enzyme deficiencies, follow this three-question framework: (1) What accumulates proximal to the block? (2) What is deficient distal to the block? (3) What are the clinical consequences of the accumulation and deficiency? Applying this framework to 21-hydroxylase deficiency (the most common CAH): 17-OH progesterone accumulates → shunted to androgens → virilization of 46,XX females; cortisol and aldosterone deficient → salt wasting + hypotension (the opposite of 17α-hydroxylase deficiency).

SECTION 7

Key Enzyme Deficiencies & Disorders of Sexual Development

Reproductive physiology becomes clinically testable when enzyme deficiencies or receptor abnormalities disrupt the normal pathways. The table below compares the three most commonly tested enzyme deficiencies in the context of congenital adrenal hyperplasia and sexual differentiation disorders. Understanding the pattern of hormone accumulation versus deficiency is the key to rapid diagnosis.

Feature	21-Hydroxylase Deficiency	11β-Hydroxylase Deficiency	17α-Hydroxylase Deficiency
Frequency	Most common CAH (~90%)	Second most common (~5–8%)	Rare
Elevated marker	17-OH progesterone	11-deoxycortisol, 11-deoxycorticosterone	DOC, corticosterone
Blood pressure	↓ (salt wasting in severe form)	↑ (11-deoxycorticosterone is a mineralocorticoid)	↑ (excess DOC)
Sex steroids	↑ Androgens (virilization of XX)	↑ Androgens (virilization of XX)	↓ All sex steroids (undervirilization of XY)
Ambiguous genitalia in	46,XX females	46,XX females	46,XY males (phenotypic female)
Potassium	↑ (hyperkalemia in salt wasting)	↓ (hypokalemia)	↓ (hypokalemia)

Three most commonly tested CAH enzyme deficiencies on USMLE Step 1

✦

DIAGNOSTIC PATTERN RECOGNITION

A simple mnemonic for Board examinations: "Hypertension + hypokalemia + undervirilized XY" → 17α-hydroxylase deficiency. "Hypertension + hypokalemia + virilized XX" → 11β-hydroxylase deficiency. "Hypotension + hyperkalemia + virilized XX" → 21-hydroxylase deficiency. The blood pressure and potassium pattern immediately localizes the block, while the genital phenotype confirms the direction of sex steroid perturbation.

Other High-Yield Disorders of Sexual Development

5α-Reductase Deficiency: 46,XY with ambiguous genitalia at birth, virilization at puberty (due to testosterone surge). Testes present, Wolffian structures present, external genitalia undervirilized because DHT is needed for prostate and external genital development.
Complete Androgen Insensitivity Syndrome (CAIS): 46,XY with female external genitalia, breast development (aromatization of testosterone to estrogen), absent uterus (AMH still functional), testes in inguinal canals or labia. Testosterone and LH are elevated.
Aromatase Deficiency: 46,XX with virilization (excess androgens cannot be converted to estrogens), absent breast development, maternal virilization during pregnancy due to placental inability to aromatize fetal DHEA-S to estriol.
Kallmann Syndrome: Failure of GnRH neuron migration from the olfactory placode → hypogonadotropic hypogonadism + anosmia. Both FSH and LH are low; treated with pulsatile GnRH or exogenous gonadotropins.

SECTION 8

Fertilization, Implantation & Early Embryonic Development

The transition from reproductive physiology to developmental biology occurs at fertilization, which normally takes place in the ampulla of the fallopian tube. Sperm must undergo capacitation (cholesterol removal from the plasma membrane, increasing membrane fluidity and Ca²⁺ influx) in the female reproductive tract before the acrosome reaction can occur. The acrosome reaction releases hyaluronidase and acrosin, enabling penetration of the corona radiata and zona pellucida. Sperm binding to ZP3 glycoprotein triggers the acrosome reaction, while binding to ZP2 facilitates penetration. The resulting cortical reaction releases cortical granule contents that modify ZP glycoproteins, establishing the block to polyspermy.

Stage	Timing	Key Events
Fertilization	Day 0–1	Acrosome reaction, cortical reaction, formation of diploid zygote, completion of meiosis II in oocyte
Cleavage	Days 1–3	Mitotic divisions without growth (total cell mass stays constant); 2-cell → 4-cell → 8-cell → morula; cells called blastomeres
Compaction & Morula	Day 3–4	Tight junctions form between outer cells; inner cell mass (embryoblast) vs. outer cell mass (trophoblast) begin to differentiate
Blastocyst	Days 4–5	Fluid-filled cavity (blastocele) forms; inner cell mass gives rise to embryo; trophoblast gives rise to placenta
Implantation	Days 6–7	Blastocyst hatches from zona pellucida; syncytiotrophoblast invades endometrium; begins secreting hCG to rescue corpus luteum
Bilaminar disc	Week 2	Epiblast and hypoblast form; amniotic cavity and yolk sac develop ('week of 2s')
Gastrulation	Week 3	Primitive streak → three germ layers (ectoderm, mesoderm, endoderm); neural plate forms ('week of 3s')

Timeline from fertilization to early embryonic development

Twinning

The timing of embryo splitting determines the type of monozygotic twinning. Splitting at the two-cell stage (days 0–3) produces dichorionic-diamniotic twins (separate placentas and amniotic sacs). Splitting at the inner cell mass stage (days 4–8) produces monochorionic-diamniotic twins (shared placenta, separate sacs). Splitting at days 8–12 produces monochorionic-monoamniotic twins (shared placenta and sac). Splitting after day 13 results in conjoined twins. This progression is frequently tested and maps directly onto the developmental timeline above.

ℹ

Forward Connection

These early developmental stages connect directly to advanced embryology topics tested in Step 1: teratogen susceptibility windows (weeks 3–8 are the critical period for major organ malformations), neural crest cell migration disorders (DiGeorge, Hirschsprung, Waardenburg), and placental pathology (molar pregnancies, twin-to-twin transfusion syndrome). Understanding the chronologic framework laid out above provides the backbone for all of these topics.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A 26-year-old woman reports regular menstrual cycles every 32 days. She is trying to conceive and asks her physician on which day ovulation most likely occurs and what hormone directly triggers it. Which of the following best describes the timing and triggering event of ovulation in this patient? (A) Day 14; LH surge triggered by sustained high estradiol (B) Day 18; FSH surge triggered by low inhibin levels (C) Day 18; LH surge triggered by sustained high estradiol (D) Day 18; progesterone surge triggering follicular rupture

Show answer

The correct answer is (C) Day 18; LH surge triggered by sustained high estradiol. Step-by-step reasoning: (1) The luteal phase is fixed at 14 days, so ovulation = cycle length − 14 = 32 − 14 = day 18. (2) The direct trigger is the LH surge, which is induced by sustained estradiol levels exceeding approximately 200 pg/mL for 48 hours during the late follicular phase—a unique example of positive feedback in the HPG axis. (3) The LH surge activates collagenase and prostaglandin synthesis in the follicular wall, leading to stigma formation and oocyte release. (A) is incorrect because although it correctly identifies the LH surge mechanism, day 14 applies only to a standard 28-day cycle; in a 32-day cycle, ovulation occurs on day 18. (B) is incorrect because FSH, though it rises slightly at mid-cycle, is not the direct trigger of ovulation; furthermore, inhibin levels fall in the late follicular phase but this does not constitute the triggering mechanism. (D) is incorrect because progesterone does not surge before ovulation and does not trigger follicular rupture. Progesterone rises only after ovulation, secreted by the newly formed corpus luteum during the luteal phase. Attributing follicular rupture to progesterone is a common misconception; the actual trigger is the LH surge acting on the pre-ovulatory follicle.

Question 2: BASIC CALCULATION

A primary oocyte undergoes meiosis I at ovulation. If it is subsequently fertilized, how many total chromosomes are present in the resulting zygote, and how many chromatids were present in the primary oocyte at the start of meiosis I?

Show answer

The zygote contains 46 chromosomes (2n) — 23 from the secondary oocyte (which completes meiosis II upon sperm penetration) and 23 from the sperm. At the start of meiosis I, the primary oocyte has already undergone S-phase DNA replication, giving it 46 chromosomes each composed of 2 sister chromatids, for a total of 92 chromatids and a DNA content of 4C. Note the key distinction: the chromosome number remains 2n = 46 (no new chromosomes were created), but the DNA content is 4C because every chromosome has been duplicated into two sister chromatids. Conflating chromosome number with chromatid count is a classic Step 1 pitfall — always clarify which stage of the cell cycle is being asked about.

Question 3: INTERMEDIATE

A newborn 46,XX infant presents with ambiguous genitalia (clitoromegaly, labioscrotal fusion), hypotension, hyperkalemia, and hyponatremia. Serum 17-hydroxyprogesterone is markedly elevated. Which enzyme is deficient, and why does the accumulation of precursor lead to virilization?

Show answer

The enzyme deficient is 21-hydroxylase (CYP21A2), the most common cause of congenital adrenal hyperplasia. 21-Hydroxylase is needed to convert 17-OH progesterone → 11-deoxycortisol (cortisol pathway) and progesterone → 11-deoxycorticosterone (aldosterone pathway). When blocked, 17-OH progesterone accumulates and is shunted into the androgen synthesis pathway (via 17,20-lyase activity of CYP17), producing excess DHEA and androstenedione, which are converted to testosterone. This excess androgen causes virilization of the 46,XX fetus. Cortisol deficiency removes negative feedback on ACTH, further driving adrenal hyperplasia and androgen overproduction. Aldosterone deficiency causes the salt-wasting phenotype with hyponatremia, hyperkalemia, and hypotension.

Question 4: APPLIED

A 28-year-old woman with infertility undergoes ovulation induction with clomiphene citrate. Explain the mechanism by which this selective estrogen receptor modulator (SERM) induces ovulation, and predict the potential complication of multiple gestations.

Show answer

Clomiphene citrate acts as an estrogen receptor antagonist at the hypothalamus and anterior pituitary, blocking the negative feedback of endogenous estradiol. The hypothalamus 'perceives' low estrogen and increases GnRH pulse frequency and amplitude, leading to increased FSH and LH secretion. The elevated FSH stimulates recruitment and maturation of multiple follicles simultaneously, rather than the usual single dominant follicle selection. Because multiple follicles may reach maturity and ovulate in response to the ensuing LH surge, the risk of multiple gestations (particularly dizygotic twins) increases to approximately 5–10% with clomiphene, compared to ~1% baseline. This question tests integration of HPG axis feedback, pharmacology (SERM mechanism), and clinical reproductive endocrinology.

Question 5: CRITICAL THINKING

A 17-year-old 46,XY patient presents with phenotypically female external genitalia, bilateral inguinal masses, normal breast development, absent axillary and pubic hair, primary amenorrhea, and a blind-ending vaginal pouch. Testosterone levels are elevated, LH is elevated, and there is no uterus on imaging. Construct a pathophysiologic explanation that accounts for each clinical finding, and contrast this condition with 5α-reductase deficiency in terms of pubertal virilization.

Show answer

This presentation is consistent with complete androgen insensitivity syndrome (CAIS), caused by a loss-of-function mutation in the androgen receptor gene (X-linked recessive). The patient has testes (SRY gene present) located in the inguinal canals (the bilateral masses). These testes produce AMH, which causes Müllerian duct regression (hence no uterus or upper vagina). However, because the androgen receptor is nonfunctional, testosterone cannot exert its effects: Wolffian duct development is impaired (no epididymis, vas deferens, or seminal vesicles), and external genitalia default to female phenotype. Breast development occurs because excess testosterone is aromatized to estradiol in peripheral tissues. Pubic and axillary hair are androgen-dependent and therefore absent. LH is elevated due to loss of negative feedback (androgen receptor-mediated) at the hypothalamus/pituitary. In contrast, 5α-reductase deficiency preserves androgen receptor function—testosterone still works, but DHT cannot be produced. At puberty, the massive rise in testosterone partially compensates, causing virilization (voice deepening, muscle mass increase, phallic growth), which does NOT occur in CAIS because no androgen signaling is possible regardless of testosterone levels.

SUMMARY

Reproductive Physiology & Development — Summary

Summary

Reproductive physiology is governed by the hypothalamic-pituitary-gonadal (HPG) axis, in which pulsatile GnRH drives anterior pituitary secretion of FSH and LH, which regulate gonadal steroidogenesis (from cholesterol through pregnenolone, androgens, and estrogens) and gametogenesis. Negative feedback from sex steroids and inhibins maintains homeostasis, while a unique midcycle positive feedback loop from sustained estradiol triggers the LH surge and ovulation. The two-cell, two-gonadotropin model of the ovary and the Sertoli-Leydig cell cooperation in the testis are essential frameworks for understanding normal and pathologic states.

Following fertilization in the ampulla of the fallopian tube, the zygote undergoes cleavage, morula formation, and blastocyst differentiation before implanting on day 6–7. Early embryonic development proceeds through bilaminar disc (week 2) and gastrulation (week 3, establishing three germ layers). Sexual differentiation depends on the SRY gene, testosterone/DHT, and AMH. Enzyme deficiencies in steroidogenesis (21-hydroxylase, 11β-hydroxylase, 17α-hydroxylase) and receptor defects (CAIS, 5α-reductase deficiency) produce predictable clinical phenotypes based on what accumulates and what is deficient—a framework that enables rapid pattern recognition for USMLE Step 1 vignettes.